Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
1980
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
abstract

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
no guideline available
Version / remarks:
The study was conducted prior to OECD guidance. However, the general principles are similar.
Principles of method if other than guideline:
Standard MT testing strategy for studies conducted according to Magnusson and Kligman.
GLP compliance:
no
Remarks:
Standard MT testing strategy for studies conducted according to Magnusson and Kligman.
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The in vivo study "Capacity of allergic sensitization determined by the maximisation test (MT) on guina pigs" was already available (performed in 1980) and reliable to evaluate the skin sensitization potential and the classification determination.

Test material

Constituent 1
Chemical structure
Reference substance name:
Ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate
EC Number:
261-020-5
EC Name:
Ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate
Cas Number:
57934-97-1
Molecular formula:
C13H22O2
IUPAC Name:
ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate
Constituent 2
Chemical structure
Reference substance name:
Ethyl 2,3,6,6-tetramethylcyclohex-2-ene-1-carboxylate
EC Number:
278-776-7
EC Name:
Ethyl 2,3,6,6-tetramethylcyclohex-2-ene-1-carboxylate
Cas Number:
77851-07-1
Molecular formula:
C13H22O2
IUPAC Name:
ethyl 2,3,6,6-tetramethylcyclohex-2-ene-1-carboxylate
Specific details on test material used for the study:
Test material name: Givescone

In vivo test system

Test animals

Species:
guinea pig
Strain:
not specified
Sex:
not specified
Details on test animals and environmental conditions:
Standard MT testing strategy for studies conducted according to Magnusson and Kligman.

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
other: FCA
Concentration / amount:
5%
Route:
epicutaneous, occlusive
Vehicle:
petrolatum
Concentration / amount:
25%
Day(s)/duration:
2 days
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
petrolatum
Concentration / amount:
10%, 3%, 1%
Day(s)/duration:
24 hours
No. of animals per dose:
19 animals were used
Details on study design:
Standard MT testing strategy for studies conducted according to Magnusson and Kligman.
Positive control substance(s):
no

Study design: in vivo (LLNA)

Vehicle:
other: Petrolatum
Concentration:
25% in petrolatum, challenge at 1%, 3%, 10%.
No. of animals per dose:
19

Results and discussion

Positive control results:
NA

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
1%, 3%, 10%
No. with + reactions:
0
Total no. in group:
19
Clinical observations:
no effects
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
1%, 3%, 10%
No. with + reactions:
0
Total no. in group:
19
Clinical observations:
No effects

In vivo (LLNA)

Results
Parameter:
other:
Remarks on result:
not determinable

Any other information on results incl. tables

Challenge patch tests 3 and 5 weeks after the beginning of the treatment are negative.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the test conditions used in the Maximisation test, Givecsone does not sensitize Guinea pigs.
Executive summary:

This study was performed to investigate the potential of Givescone to sensitize in a maximisation test (MT) on guina pigs.

On day 0, the animals were injected intradermally with 0.1 ml of a 5% solution of the compound, with 0.1 ml of a 5% emulsion of the compound in FCA and with 0.1 ml of FCA alone, each injection was given twice. In addition, on day 8 the compound, dissolved in petrolatum up to 25% was applied to a clippped skin area of the neck and kept under occlusive bandage for 2 days (total of 20 mg intradermally plus 250 mg epicutaneously). On day 21, an occlusive patch test with the compound in petrolatum was applied to the flank for 24 hours and the reactions were read 24 and 48 hours after removing the patch. Under the test conditions used in the Maximisation test, Givescone does not sensitize Guinea pigs.